GSK Norway

GSK’s purpose is to unite science, talent and technology to get ahead of disease together. Our research and development focus is to deliver new vaccines and medicines using the science of the immune system, human genetics and advanced technologies. This focus enables us to get ahead of infectious diseases, HIV, cancer and immune-mediated and respiratory diseases. Our large portfolio of vaccines helps protect people at all stages of life. In Norway, GSK has around 60  employees, with a turnover of about NOK 700 million. Haleon (GSK Consumer Healthcare until July 2022) will be a global leader 100% focused on consumer health.